FGFR3 / IGH t(4;14) Fusion probe hybridized to MM patient material showing t(4;14) translocation (2RG1R1G). Image kindly provided by Prof. Jauch, Heidelberg.
FGFR3 / IGH t(4;14) Fusion probe hybridized to MM patient material showing t(4;14) translocation (2RG1R1G). Image kindly provided by Prof. Jauch, Heidelberg.
RUO - FGFR3 / IGH
The t(4;14) translocation is undetectable by conventional cytogenetics. The breakpoints on chromosome 4 occur within an approximately 113-kb region located in small part of a conserved gene cluster including the transforming acidic coiled-coil protein 3 (TACC3), fibroblast growth factor receptor 3 (FGFR3), and multiple myeloma SET domain-containing protein (MMSET). The translocation is indicative for poor survival and poor response to chemotherapy. The FGFR3 / IGH t(4;14)(p16;q32) Fusion specific FISH probe is optimized to detect the reciprocal translocation t(4;14) in a dual-color, dual-fusion assay.
References: Chesi et al, 1997, Nat Genet, 16; 260-264. Finelli et al, 1999, Blood, 94; 724-732.
제품
제품
KI-10602
FGFR3/IGH t(4;14) Fusion
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.
KR
